Pharma companies' print advertising spend continues to slow, says Cegedim

Audited marketing figures on pharmaceutical companies' print advertising investments shows a total spend of438 million euros ($574.7 million) for on a moving annual total for the 12 months ending September 2011 across the 10 leading markets.

10 key markets were analysed, says health care research firm Cegedim: Top five Europe (France, Germany, Italy, Spain, and the UK), the USA, Japan, China, Brazil and Russia.

The industry experienced a particularly difficult 12 month period to September 2010, where the decrease in print advertising investments was 10%. Use of advertising in medical journals continued to decline for the following 12 month period ending September 2011, however, not to the same extent, dropping just 4%.